Data / Form D filings / Lyric Pharmaceuticals Inc.
Lyric Pharmaceuticals Inc.: Form D filings
Lyric Pharmaceuticals Inc., a pharmaceuticals company in South San Francisco, CA, filed 2 Form D notices with the SEC between 2015 and 2017. The latest, on April 24, 2017, reports $26.8 million sold of a $33.9 million offering to 13 investors.
Find out what Lyric Pharmaceuticals Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 601 GATEWAY BLVD., SUITE 1020, South San Francisco, CA, 94080
- Phone
- (650) 866-8070
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2013
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1634389
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 24, 2017 | Amendment | $33,885,598 | $26,785,593 | $7,100,005 | 13 | Feb 11, 2015 | sec.gov |
| Feb 26, 2015 | New notice | $21,306,689 | $7,814,562 | $13,492,127 | 12 | Feb 11, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Wurtman | Executive Officer, Director | |
| Sanford Zweifach | Director | |
| Jason Hong | Director | |
| Casey Cunningham | Director | |
| M. Scott Harris | Executive Officer | |
| Niall O'Donnell | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Apr 24, 2017 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Lyric Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.